From intensifying therapy in ctDNA-positive bladder cancer to scaling it back in ctDNA-negative colon cancer, new data from ...

FX-909, a first-in-class investigational oral small molecule inhibitor of peroxisome proliferator-activated receptor gamma ...

Adjuvant nivolumab (Opdivo) continued to show benefits in disease-free survival (DFS) compared with placebo in patients with muscle-invasive urothelial carcinoma (MIUC) who underwent radical surgery, ...

Blood in urine, known as haematuria, can signal kidney cancer. This symptom, whether visible or microscopic, demands ...

Brigadeer Gareth Collett protected countless lives in his work, and he is now aiming to save hundreds more with research into ...

Patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) have a significantly higher overall risk of developing cancer, according to a systematic review and meta-analysis ...

Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...

Without an easy way to screen and with nondescript symptoms, ovarian cancer is often caught in late stages, requiring massive ...

Nanobiotix S.A. has surged on strong NBTXR3 data, but its sole asset is out-licensed to Johnson & Johnson. Learn more about ...

To improve the quality of life of people with cancer, oncologists have regularly recommended exercise. Staying fit can make ...